About BrainStorm Cell
BrainStorm Cell is a company based in Petah Tikva (Israel) founded in 2000. The company has 27 employees as of December 31, 2024. BrainStorm Cell offers products and services including NurOwn. BrainStorm Cell operates in a competitive market with competitors including Mesoblast, RoosterBio, SanBio, Osiris and SCM Lifescience, among others.
- Headquarter Petah Tikva, Israel
- Employees 27 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Brainstorm Cell Therapeutics Inc.
-
Annual Revenue
Not available
-
Net Profit
-$11.62 M (USD)32.39as on Dec 31, 2024
-
EBITDA
-$11.45 M (USD)45.91as on Dec 31, 2024
-
Latest Funding Round
$1 M (USD), Post-IPO
Feb 09, 2026
-
Investors
National MS Society
& 4 more
-
Employee Count
27
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of BrainStorm Cell
BrainStorm Cell is a publicly listed company on the OTC with ticker symbol BCLI in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of BrainStorm Cell
BrainStorm Cell offers a comprehensive portfolio of products and services, including NurOwn.
Investigational platform for producing autologous MSC-NTF cells for neurodegenerative diseases.
People of BrainStorm Cell
Unlock access to complete
Unlock access to complete
Funding Insights of BrainStorm Cell
Investors in BrainStorm Cell
BrainStorm Cell has secured backing from 5 investors, including institutional investors. Prominent investors backing the company include National MS Society, Israel Innovation Authority and I AM ALS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A non-profit organization focused on ALS support and advocacy is operated.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Business development in Israel is supported by a government organization.
|
Locked | Locked | Locked |
Investor details for BrainStorm Cell
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BrainStorm Cell
Investment portfolio details for BrainStorm Cell
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BrainStorm Cell
Detailed financials for BrainStorm Cell
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Brainstorm Cell Comparisons
Peer comparison for BrainStorm Cell
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BrainStorm Cell
BrainStorm Cell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Mesoblast, RoosterBio, SanBio, Osiris and SCM Lifescience, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Biotherapeutics derived from proprietary adult stem cell-based technologies
|
|
| Locked | Locked | Locked |
Developer of human mesenchymal stem cells and extracellular vesicles
|
|
| Locked | Locked | Locked |
Regenerative cell medicines for neurological disorders are developed.
|
|
| Locked | Locked | Locked |
Stem cell-based regenerative medicines are developed and marketed.
|
|
| Locked | Locked | Locked |
Mesenchymal stem cells are developed for therapeutics using proprietary methods.
|
Detailed competitors of BrainStorm Cell
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Brainstorm Cell
Complete news archive for BrainStorm Cell
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BrainStorm Cell
BrainStorm Cell was founded in 2000 and raised its 1st funding round 12 years after it was founded.
BrainStorm Cell is headquartered in Petah Tikva, Israel. It is registered at Petah Tikva, Central District, Israel.
Chaim Lebovits is the current CEO of BrainStorm Cell.
As of Dec 31, 2024, the latest employee count at BrainStorm Cell is 27.
BrainStorm Cell Therapeutics was founded in 2000 in Petah Tikva, Israel, within the biotechnology sector. Autologous stem cell therapies are developed for neurodegenerative disorders such as ALS, multiple sclerosis, and Parkinsons disease. The NurOwn platform is utilized to differentiate mesenchymal stem cells into neurotrophic factor-secreting cells for transplantation near affected sites. Animal models of these diseases, including Huntingtons and peripheral nerve injury, are employed in research and testing.
BrainStorm Cell's top competitors include RoosterBio, Mesoblast and SanBio.
BrainStorm Cell offers NurOwn.
Yes, BrainStorm Cell is publicly traded on OTC under the ticker symbol BCLI.
BrainStorm Cell has 5 investors. Key investors include National MS Society, Israel Innovation Authority, I AM ALS, ALS Association, and Portalsaude.
The ticker symbol of BrainStorm Cell is BCLI on OTC.